LBI-0942
THERAPEUTIC AREA
SOLID TUMOR CANCER
Indications
Breast, Lung, Pancreas Cancer
REGULATORY PATHWAY
Generic ANDA
TARGET INDICATION
Contract development funds company and builds out commercial manufacturing process for Luminus Nano medicines
CURRENT DEVELOPMENT STATUS
Active CMC development in process
NEXT DEVELOPMENT PHASE
Clinical studies
TIME TO HUMAN BENEFIT
Bioequivalence study to begin in the 1st quarter of 2020
IMMEDIATE FUNDING REQUIRED?
No, fully funded by partner